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Abstract: The frequent occurrence of Moorea producens (formerly Lyngbya majuscula) 
blooms has been associated with adverse effects on human health. Hoiamide A is a structurally 
unique cyclic depsipeptide isolated from an assemblage of the marine cyanobacteria  
M. producens and Phormidium gracile. We examined the influence of hoiamide A on 
neurite outgrowth in neocortical neurons and found that it suppressed neurite outgrowth 
with an IC50 value of 4.89 nM. Further study demonstrated that hoiamide A stimulated 
lactic acid dehydrogenase (LDH) efflux, nuclear condensation and caspase-3 activity with 
EC50 values of 3.66, 2.55 and 4.33 nM, respectively. These data indicated that hoiamide A 
triggered a unique neuronal death profile that involves both necrotic and apoptotic 
mechanisms. The similar potencies and similar time-response relationships between LDH 
efflux and caspase-3 activation/nuclear condensation suggested that both necrosis and 
apoptosis may derive from interaction with a common molecular target. The broad-spectrum 
caspase inhibitor, Z-VAD-FMK completely inhibited hoiamide A-induced neurotoxicity. 
Additionally, hoiamide A stimulated JNK phosphorylation, and a JNK inhibitor attenuated 
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hoiamide A-induced neurotoxicity. Collectively, these data demonstrate that hoiamide  
A-induced neuronal death requires both JNK and caspase signaling pathways. The potent 
neurotoxicity and unique neuronal cell death profile of hoiamide A represents a novel 
neurotoxic chemotype from marine cyanobacteria.  
Keywords: apoptosis; caspase; c-Jun N-terminal kinase; hoiamide A; necrosis 
 
1. Introduction 
Marine cyanobacteria are prolific producers of structurally novel and biologically active natural 
products and are especially rich in metabolites with toxic properties [1–4]. Moorea producens 
(formerly Lyngbya majuscula) is a pantropical marine cyanobacterium, blooms of which have been 
occurring for decades around the world, particularly in Florida’s Gulf Coastal region of Sanibel Island 
and the east coast of Queensland, Australia. These blooms of M. producens are reported to have 
adverse effects on both human populations and domestic animals [5,6], including respiratory irritation, 
eye inflammation, severe contact dermatitis, gastrointestinal distress as well as fever and headache 
symptoms [5,7–9]. Chemical investigations of M. producens have revealed several classes of structurally 
unique secondary metabolites that are toxic to mammalian cells [7,10–21]. However, the modes of 
action of these natural toxins are less studied. 
Hoiamide A is a novel bioactive cyclic depsipeptide isolated from an environmental assemblage of 
the marine cyanobacteria Moorea producens and Phormidium gracile collected in Papua New  
Guinea [22]. This stereochemically complex metabolite possesses a highly unusual structure that likely 
derives from a mixed peptide-polyketide biogenetic origin, and includes a peptidic section featuring a 
ketide-extended and S-adenosyl methionine modified isoleucine moiety, a triheterocyclic fragment 
bearing two-methylated thiazolines and one thiazole, and a highly oxygenated and methylated  
C15-polyketide substructure [22]. After discovering hoiamide A, the structurally related analogs, 
hoiamides B–D, were purified from either Symploca sp. or an assemblage of Symploca sp. and 
Oscillatoria cf. sp. [23,24]. Due to its unique and intriguing structure, hoiamide C became the target of 
total organic synthesis; this was successfully accomplished in 2011 [25]. 
In primary cultures of neocortical neurons, we have shown that pure hoiamide A stimulated sodium 
influx with a low micromolar EC50 value. The triggered sodium influx was abrogated by co-application 
of the sodium channel blocker tetrodotoxin (TTX), suggesting that hoiamide A may act as a voltage 
gated sodium channel (VGSC) activator [22]. Direct evidence of hoiamide A interaction with VGSCs 
was derived from its ability to inhibit [3H]batrachotoxin binding to VGSCs [22]. Further examination 
of hoiamide A’s effects on sodium influx demonstrated that hoiamide A is a partial agonist of 
neurotoxin site 2 on the voltage-gated sodium channel [22]. In addition to their action on the VGSCs, 
hoiamide A and hoiamide B suppressed spontaneous Ca2+ oscillations in primarily cultures of cortical 
neurons at sub-micromolar concentrations. This latter effect was independent of modification of VGSC 
activity [23]. In contrast, the linear analog, hoiamide C, was inactive in disrupting spontaneous Ca2+ 
oscillations [23]. Another linear analog, hoiamide D, was found to be an inhibitor of p53/MDM2 
interaction at micromolar concentrations, an attractive target for anti-cancer drug development [24]. 
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The hoiamides therefore appear to interact with several biologically significant molecular targets with 
distinct affinities. 
Sodium channel activators have been shown to stimulate neurite outgrowth through enhancement of 
NMDA receptor function in neocortical neurons [26,27]. In the present study we explored the 
influence of hoiamide A on neurite outgrowth in neocortical neurons. In contrast to the neurite 
outgrowth stimulated by sodium channel activators, hoiamide A produced a concentration-dependent 
neurite retraction in neocortical neurons having an IC50 value of 4.89 nM with a 95% Confidence 
Interval (95% CI) of 1.14–20.9 nM. Additional studies demonstrated that hoiamide A increased LDH 
efflux, produced nuclear condensation and stimulated caspase-3 activity all with low nanomolar 
potency. These data indicate that hoiamide A triggers a unique profile of neuronal death in neocortical 
neurons that involves both necrotic and apoptotic mechanisms. The actions of hoiamide A on neurite 
retraction and neurotoxicity were three orders of magnitude more potent than its action on sodium 
channels, thus excluding VGSCs as the molecular target responsible for neurotoxicity. Further 
pharmacological evaluation demonstrated that hoiamide A-induced neurotoxicity was dependent on 
both caspase and JNK activation.  
2. Results  
2.1. Hoiamide A Produces Neurite Retraction in Neocortical Neurons 
The structure of hoiamide A was shown in Figure 1. Given the partial agonist activity of hoiamide 
A at neurotoxin site 2 on VGSCs [22] and the previously demonstrated stimulation of neurite 
outgrowth by VGSC activators such as PbTx-2 and antillatoxin [26,27], we evaluated the influence of 
hoiamide A on neurite outgrowth in neocortical neurons. Three hours post plating the cells were 
treated with vehicle (0.1% DMSO) and different concentrations of hoiamide A for 24 h. The cells were 
then labelled with DiI dye using the Helios Gene Gun System and the images were taken on an 
Olympus IX71 fluorescent microscope. Rather than an increase in neurite outgrowth, hoiamide A 
produced a concentration-dependent neurite retraction in immature neocortical neurons (Figure 2). The 
IC50 value revealed by non-linear regression analysis was 4.89 nM with a 95% Confidence Interval 
(95% CI) of 1.14–20.9 nM.  
 
Figure 1. Chemical structure of Hoiamide A. 
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Figure 2. Hoiamide A induced retraction of neurites in neocortical neurons. (a) Representative 
images of DiI-loaded immature neocortical neurons treated with various concentrations of 
hoiamide A for 24 h; (b) Concentration-response relationship for hoiamide A on neurite 
retraction at 24 h post plating. Experiments were performed three times and each point 
represents the mean value derived from analysis of 25–30 neurons.  
2.2. Hoiamide A Produces LDH Efflux in Neocortical Neurons 
Neocortical neurons exposed to hoiamide A (30 nM) for 8, but not 2 h displayed significant LDH 
efflux (data not shown). After a 24 h duration of exposure, hoiamide A produced robust neuronal death 
as reflected in significantly elevated levels of LDH efflux. This hoiamide A neurotoxicity was 
concentration-dependent with an EC50 value of 3.66 nM (1.12–6.33, 95% CI) (Figure 3). To further 
confirm hoiamide A-induced neurotoxicity, neocortical neurons were treated with various concentrations 
of hoiamide A for 24 h and then stained with fluorescein diacetate (FDA) and propidium iodide (PI). 
As shown in Figure 4a, the percentage of live cells (green, FDA fluorescence) gradually decreased 
whereas the percentage of dead cells (red, PI fluorescence) gradually increased with increased 
concentrations of hoiamide A. Figure 4b depicts the concentration-response curve for hoiamide  
A-induced neurotoxicity as determined by PI measurements, and was consistent with the results of the 
LDH assay [EC50 = 3.53 nM (1.89–6.57, 95% CI)].  
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Figure 3. Neurotoxic concentration-response relationship for hoiamide A induced LDH 
efflux in neocortical neurons exposed for 24 h. Individual points represent the mean ± S.E.M. 
from three separate experiments performed in triplicate. 
 
Figure 4. Hoiamide A-induced neurotoxicity. (a) Representative images for FDA and PI 
double-stained neocortical neurons treated with various concentrations of hoiamide A for 
24 h; (b) Concentration-response relationship for hoaimide A-induced neuronal death 
visualized by PI staining. Experiments were performed three times each in triplicate. 
2.3. Hoiamide A Stimulates Caspase-3 Activation in Neocortical Neurons 
Apoptosis and necrosis are generally recognized as two distinct pathways of cell death. Given that 
LDH efflux represents a useful assay for necrotic cell death, we next investigated whether hoiamide A 
was capable of producing apoptotic cell death in neocortical neurons. Caspase proteases play a critical 
role in apoptotic neuronal death and the activation of caspases has been considered to be an early 
marker of apoptotic cell death. We accordingly tested the influence of hoiamide A on caspase-3 
activity in neocortical neurons. Caspase-3 activity was significantly enhanced after 8, but not 2 h of 
treatment with hoiamide A (data not shown). As depicted in Figure 5, treatment with hoiamide A for 
24 h produced a robust and concentration-dependent stimulation of caspase-3 activity with an EC50 
value of 4.36 nM (3.01–6.33, 95% CI).  
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Figure 5. Concentration-response relationship for hoiamide A-induced caspase-3 activation. 
Experiments were repeated in three independent cultures, each in triplicate. 
2.4. Hoiamide A Produces Nuclear Condensation in Neocortical Neurons  
An additional characteristic of apoptotic cell death is the morphological change that occurs to 
nuclear chromatin that manifests as nuclear condensation. We therefore evaluated the effects of 
hoiamide A on nuclear morphology in neocortical neurons. Neocortical neurons displayed significant 
nuclear morphological changes after 24 h exposure to hoiamide A (Figure 6a). Hoiamide A produced a 
robust and concentration-dependent stimulation of nuclear condensation and fragmentation in 
neocortical neurons with an EC50 value of 2.55 nM (1.23–5.30, 95% CI) (Figure 6b).  
 
Figure 6. Hoiamide A stimulation of nuclear condensation in neocortical neurons.  
(a) Representative neocortical neurons after exposure to 0.1% DMSO for 24 h;  
(b) Representative neocortical neurons exposed to 30 nM hoiamide A for 24 h. Neocortical 
neuron condensed nuclei were revealed with Hoechst 33342 dye staining (indicated  
with arrows); (c) Quantification of concentration-response relationship for hoiamide  
A-induced nuclear condensation. Experiments were repeated in three independent cultures, 
each in triplicate. 
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2.5. Tetrodotoxin (TTX) is without Effect on Hoiamide A-Induced Neurotoxicity  
Given the previous demonstration that hoiamide A is a low affinity VGSC partial agonist at 
neurontoxin site 2 [22], we next determined whether hoiamide A-induced neurotoxicity in neocortical 
neurons involved activation of VGSCs. Neocortical neurons were exposed to TTX, an inhibitor of 
VGSCs, for 1h prior to the addition of 30 nM hoiamide A. This pretreatment with TTX did not afford a 
protective effect against hoiamide A-induced LDH efflux (Figure 7). 
 
Figure 7. Lack of influence of TTX on hoiamide A-induced LDH efflux. TTX was without 
protective effect on hoiamide A-induced LDH efflux. These data were obtained from two 
independent cell cultures each performed in triplicate (** p < 0.01, hoiamide A vs. vehicle). 
2.6. Caspase Inhibitor, Z-VAD-FMK, Antagonizes Hoiamide A-Induced Neurotoxicity 
Given that hoiamide A stimulated caspase-3 activity, we evaluated the role of a broad-spectrum 
caspase inhibitor, Z-VAD-FMK, on hoiamide A-induced neurotoxicity in neocortical neurons. 
Neocortical neurons were pretreated with Z-VAD-FMK (100 μM) for 1 h prior to addition of 30 nM 
hoiamide A. Pre-treatment with Z-VAD-FMK produced a nearly complete inhibition of both hoiamide 
A-induced LDH efflux (Figure 8) and nuclear condensation (Figure 9). 
 
Figure 8. Effect of Z-VAD-FMK (100 μM) on hoiamide A-induced LDH efflux. These 
data were obtained from two independent cell cultures performed in triplicate (** p < 0.01, 
hoiamide A vs. vehicle; aa, p < 0.01, hoiamide A + Z-VAD-FMK vs. hoiamide A). 
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Figure 9. Effect of Z-VAD-FMK (100 μM) on hoiamide A-induced nuclear condensation. 
(a) Representative Hoechst 33342 stained images of neocortical neurons exposed to 0.01% 
DMSO or hoiamide A (30 nM) in the absence or presence of the caspase inhibitor  
Z-VAD-FMK (100μM); (b) Z-VAD-FMK (100 μM) suppressed hoiamide A-induced 
nuclear condensation. These data were obtained from two independent cell cultures each 
performed in quadruplicate (** p < 0.01, hoiamide A vs. vehicle; aa, p < 0.01,  
hoiamide A + Z-VAD-FMK vs. hoiamide A). 
2.7. Lack of Effect of MK-801, Nifedipine, NBQX and KBR-7943 on Hoiamide A-Induced 
Neurotoxicity in Neocortical Neurons 
To further explore the molecular mechanisms responsible for hoiamide A-induced neurotoxicity, we 
next evaluated the roles of NMDA receptors, L-type Ca2+ channels, α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors and the Na+-Ca2+ exchanger as targets for hoiamide A-induced 
neurotoxicity. Application of an NMDA receptor antagonist (MK-801, 1 μM), L-type Ca2+ channel 
antagonist (nifedipine, 1 μM), AMPA receptor antagonist (NBQX, 1 μM) or the Na+-Ca2+ exchanger 
reverse mode inhibitor (KBR-7943, 3 μM) for 1 h prior to the addition of hoiamide A (30 nM) had no 
effect on hoiamide A-induced LDH efflux (Supplementary Figure S1).  
2.8. The JNK Inhibitor, SP 600125, Protects Neocortical Neurons from Hoiamide A-Induced Neurotoxicity 
Mitogen activated protein (MAP) kinases are involved in neuronal cell death induced by multiple 
mechanisms. We therefore evaluated the effect of MAP kinase inhibitors on hoiamide A-induced 
neurotoxicity. Inhibition of the extracellularly regulated kinase (ERK) activity by U0126 (10 μM) had 
no protective effects against either hoiamide A-induced LDH efflux or nuclear condensation (Figure 10). 
The p38 kinase inhibitor, SB 203580 (10 μM), produced a modest inhibition of hoiamide A-induced 
LDH efflux; however, this effect was apparently due to inhibition of basal LDH efflux. Pretreatment 
with SB 203580 (10 μM) was without effect on either basal or hoiamide A-induced nuclear condensation. 
To evaluate the role of the JNK cascade in the neurotoxic effect of hoiamide A (30 nM), we treated 
neocortical neurons with the JNK inhibitor, SP 600125 (10 µM). Pretreatment with SP 600125 
produced a statistically significant protective effect against hoiamide A-induced LDH efflux (49% 
decrease) as well as chromatin condensation (65% decrease) (Figure 10).  
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Figure 10. (a) Effect of MAP kinase inhibitors on hoiamide A-induced LDH efflux.  
These data were obtained from two independent cell cultures each performed in triplicate 
(** p < 0.01, hoiamide A vs. vehicle; aa, p < 0.01, hoiamide A (H)+SP vs. hoiamide A; bb, 
p < 0.01, SB 203580 vs. vehicle; cc, p < 0.01, H+SB vs. hoiamide A); (b) Effect of MAP 
kinase inhibitors on hoiamide A (30 nM)-induced nuclear condensation. These data were 
obtained from two independent cell cultures each performed in triplicate. (** p < 0.01, 
hoiamide A vs. vehicle; aa, p < 0.01, H + SP vs. hoiamide A). 
2.9. Hoiamide A Stimulates JNK Phosphorylation on Neocortical Neurons 
Given the protective effects of the JNK inhibitor SP 600125 against hoiamide A-induced 
neurotoxicity, we evaluated the effect of hoiamide A on JNK phosphorylation. Exposure to hoiamide 
A (30 nM) produced a significant increase in JNK phosphorylation that peaked at 2 h (Figure 11). The 
anti-JNK antibody usually recognizes a doublet in many cell lines. However, in our neocortical 
cultures it appears that only one isoform is preferentially expressed and activated. 
 
Figure 11. Influence of hoiamide A on JNK. (a) Representative western blot for the 
influence of hoiamide A (30 nM) on JNK phosphorylation; (b) Quantification of JNK 
phosphorylation after exposure of neocortical cells to hoiamide A (30 nM) as a function of 
time. These data were pooled from four independent experiments (** p < 0.01; * p < 0.05, 
hoiamide A vs. vehicle). 
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3. Discussion 
Hoiamide A is a novel bioactive cyclic depsipeptide isolated from an environmental assemblage of 
the marine cyanobacteria M. producens and P. gracile collected in Papua New Guinea [22]. Hoiamide 
A was isolated in substantial quantities from this assemblage (0.1% of the total dry weight, 150 mg 
from 150 g dry weight cyanobacteria) [22]. In the present study we have demonstrated that at low 
nanomolar concentrations hoiamide A significantly reduced neurite outgrowth, increased LDH efflux 
and enhanced both caspase activation and nuclear condensation. These data demonstrate that hoiamide 
A is a potent neurotoxin. Blooms of M. producens (formerly, Lyngbya majuscula) have been reported 
to be associated with adverse effects on both human populations and domestic animals [5,6] including 
fever and headache consistent with a neurologic effect [5,7–9]. Whether hoiamide A is also responsible 
for adverse health effects observed during blooms of M. producens will require further examination. 
During the process of apoptosis, cells undergo several characteristic morphological changes  
such as cell shrinkage, nuclear/chromatin condensation, membrane blebbing and formation of 
apoptotic bodies [28–30]. One of the mechanisms responsible for apoptotic morphological changes is 
the activation of proteases, such as those of the caspase family, whose activation is considered to be an 
early marker of apoptosis [31,32]. We demonstrate here that hoiamide A treatment produced neuronal 
apoptosis as evidenced by both nuclear condensation and stimulation of caspase-3 activity in 
neocortical neurons; this occurred with similar potency to the observed hoiamide A-induced LDH 
efflux induced. These similar nanomolar potencies and time-response relationships between LDH 
efflux and caspase activation/nuclear condensation are consistent with a common molecular target for 
both pharmacological actions.  
An interesting feature of hoiamide A-induced neurotoxicity is that it includes both necrotic and 
apoptotic processes in neocortical neurons, and that these distinct types of cell death appear to  
occur simultaneously. The hybrid cell death is similar to that caused by another type of neurotoxin,  
the azaspiracids [33]. Azaspiracid-1 (AZA-1) produced neurotoxicity through both necrosis and 
apoptosis [33]. Whether the targets of hoiamide A and AZAs are similar is presently unknown; 
however, a critical difference between hoiamide A and AZA-1 induced neurotoxicity is that SP 600125, 
a JNK inhibitor, attenuates hoiamide A-induced neurotoxicity but not that of the AZAs [33]. Hybrid 
cell death has also been reported previously in neocortical neurons for the Na+, K+-ATPase inhibitor, 
ouabain, which produces simultaneous neurotoxicity through both necrosis and apoptosis [34–36]. 
While hoiamide A inhibition of the Na+, K+-ATPase cannot presently be ruled out, one difference 
between the neurotoxic response to hoiamide A and ouabain is that nifedipine afforded protection from 
ouabain but not hoiamide A [35]. Both hoiamide A and ouabain produce an increase in intracellular 
sodium concentration [22,34–36], however, hoiamide A-induced sodium influx is in the micromolar 
range which is three orders of magnitude less potent than the hoiamide A neurotoxicity. Therefore the 
neurotoxicity is unlikely to be derived from the increase in the intracellular sodium concentration. 
We have previously demonstrated that hoiamide A is a modest affinity (low micromolar) sodium 
channel partial agonist [22]. Compared to this action on VGSCs hoiamide A is three orders of magnitude 
more potent in producing LDH efflux, caspase activation and nuclear condensation. Moreover, TTX 
was without influence on hoiamide A-induced LDH efflux, therefore excluding VGSCs as the 
molecular target for these actions. We previously found that hoiamide A suppressed spontaneous Ca2+ 
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oscillations in primarily cultured neocortical neurons at sub-micromolar concentrations that was 
independent of an interaction with VGSCs [23]. Whether this action of hoiamide A is involved in the 
neocortical neuron death observed here is unknown; however, suppression of Ca2+ oscillations is not 
responsible for the hybrid cell death observed for AZAs [33].  
Our results here also demonstrated that treatment with hoiamide A produced a robust increase in 
caspase-3 activation. Additionally, Z-VAD-FMK, a permeable, broad-spectrum caspase inhibitor, 
produced a nearly complete suppression of both hoiamide A-induced LDH efflux and nuclear 
condensation. These data therefore demonstrate that the caspase cascade is intimately involved in 
hoiamide A-induced neurotoxicity. This is consistent with the demonstration in which the caspase 
inhibitor, Z-VAD-FMK, afforded neuroprotection against hybrid neuronal cell death induced by 
ouabain [35] and the damage in the regions of thalamus and cortex following focal ischemia [37]. 
Mitogen activated protein kinase signal transduction pathways are among the most widespread 
mechanisms of eukaryotic cell regulation [38]. Increasing evidence implicates that the JNK pathway 
plays a role as an important mediator of cell death in many cell populations. Multiple intracellular and 
extracellular signals are responsible for JNK activation in neuronal cells [39]. Our study of the 
involvement of MAPK pathways demonstrated that JNK, but not ERK or p38 inhibitors, produced an 
attenuation of both hoiamide A-induced LDH efflux and nuclear condensation. Additional evidence for 
the involvement of the JNK signaling pathway was obtained from the demonstration that hoiamide A 
stimulated JNK phosphorylation in a time dependent manner.  
In summary, we extend the previous finding that hoiamide A is a sodium channel partial agonist, by 
demonstrating that hoiamide A produces neurotoxicity in neocortical neurons with nanomolar potency. 
This neurotoxicity is independent of the activation of VGSCs. Moreover, we have demonstrated that 
hoiamide A-induced neurotoxicity occurs as a result of both necrotic and apoptotic processes. 
Although the molecular target of hoiamide A-induced neurotoxicity remains to be established, our 
results demonstrate that the observed neurotoxicity is dependent on both caspase-3 and JNK activation. 
The potent neurotoxicity and complex neuronal death profile of hoiamide A represents a novel 
neuronal chemotype from marine cyanobacteria.  
4. Materials and Methods 
4.1. Materials 
Trypsin, penicillin, streptomycin, heat-inactivated fetal bovine serum, horse serum and  
soybean trypsin inhibitor were obtained from Atlanta Biologicals (Norcross, GA, USA). Minimum 
essential medium, deoxyribonuclease (DNase), poly-L-lysine, cytosine arabinoside, Hoechest-33342, 
(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate (MK-801), 2,3-dihydro 
xy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX), 2-[2-[4-(4-Nitrobenzyloxy)phenyl] 
ethyl]isothiourea mesylate (KBR-7943), nifedipine, fluorescein diacetate, propidium iodide, 
dichloromethane and polyvinylpyrrolidone were from Sigma (St. Louis, MO, USA). Tetrodotoxin 
(TTX) was purchased from Tocris Cookson, Inc. (Ellisville, MO, USA). Anti-stress-activated protein 
kinase/c-Jun N-terminal kinase (SAPK/JNK) antibody and anti-phospho-SAPK/JNK (Thr183/Tyr185) 
were from Cell Signaling Technology (Danvers, MA, USA). Anthra[1-9-cd]pyrazol-6(2H)-one (SP 
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600125), 4-(4-Fluorophenyl)-2-[4-(methylsulfinyl) phenyl]-5-(4-pyridyl) 1H-imidazole (SB 203580), 
1,4-diamino-2,3-dicyano-1,4-bis (2-aminophenylthio) butadiene (U0126) and N-benzyloxycarbonyl-
Val-Ala-Asp fluoromethyl ketone (Z-VAD-FMK) were from Biomol International (Plymouth Meeting, 
PA, USA). 
4.2. Neocortical Neuron Culture 
Primary cultures of neocortical neurons were obtained from embryonic day 16–17 Swiss–Webster 
mice and processed as previously described [40]. Briefly, pregnant mice were euthanized by CO2 
asphyxiation and embryos were removed under sterile conditions. Neocortices were collected, stripped 
of meninges, minced by trituration with a Pasteur pipette and treated with trypsin for 25 min at 37 °C. 
The cells were then dissociated by two successive trituration and sedimentation steps in soybean 
trypsin inhibitor and DNase containing isolation buffer, centrifuged and resuspended in Eagle’s 
minimal essential medium with Earle’s salt (MEM) supplemented with 1 mM L-glutamine, 10% fetal 
bovine serum, 10% horse serum, 100 I.U./mL penicillin and 0.10 mg/mL streptomycin, pH 7.4. Cells 
were plated onto poly-L-lysine-coated 96-well clear-bottomed black-well culture plates (Corning Life 
Science, Acton, MA, USA) at a density of 1.5 × 105 cells/well. Cells were incubated at 37 °C in a 5% CO2 
and 95% humidity atmosphere. Cytosine arabinoside (10 μM) was added to the culture medium after 
24–48 h post plating to prevent the proliferation of nonneuronal cells. The culture medium was changed 
on 5, 7, and 9 days in vitro (DIV) using Neurobasal medium supplemented with B-27, 0.2 mM  
L-glutamine, 100 I.U./mL penicillin and 0.10 mg/mL streptomycin, pH 7.4. All animal use protocols 
were approved by the Creighton University Institutional Animal Care and Use Committee (IACUC). 
4.3. Lactate Dehydrogenase (LDH) Activity Assay 
Neocortical neurons cultured in 96-well plates were used for LDH efflux assay as described 
previously [33]. All assays were carried out in the presence of 0.1% dimethyl sulfoxide (DMSO), 
which by itself had no effect on LDH efflux in neocortical neurons. Neocortical neurons (8–10 DIV) 
were continuously exposed to the desired concentrations of hoiamide A in the culture medium. The 
medium was then collected and assayed for LDH activity. LDH activity was determined 
spectrophotometrically as described by [41]. Toxicity data are reported as LDH activity units per plate.  
4.4. Hoechst 33342 Staining 
Neocortical neurons cultured in 96-well plates (8–10 DIV) were exposed to hoiamide A for desired 
times. The medium was then aspirated and a concentration of 1.6 μg/mL of Hoechst 33342 dye (cell 
permeable) in Locke’s buffer (in mM: 8.6 Hepes, 5.6 KCl, 154 NaCl, 5.6 Glucose, 1.0 MgCl2, 2.3 CaCl2, 
0.0001 glycine, pH 7.4) was added to the neocortical neurons. The neurons were then incubated  
for 15 min at 37 °C in the dark. Images were then taken using an Olympus IX71 confocal microscope.  
4.5. Caspase-3 Activity Assay 
Neocortical neurons cultured in 96-well plates (DIV 8) were treated with hoiamide A for the desired 
time. The cells were then washed three times with PBS and lysed in 60 μL lysis buffer (20 mM Tris, 
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100 mM NaCl, 0.5 mM EDTA, 0.01% Triton X-100, pH 7.5). After centrifugation for 10 min at 5000× g, 
the supernatant (40 μL) was mixed with equal volume of 2× reaction buffer (20 mM PIPES, 4 mM 
EDTA, 0.2% CHAPS, 10 μM DTT, pH: 7.4) containing 25 μM of a fluorometric substrate, bisamide 
derivative of rhodamine 110 (Z-DEVD-R110), and incubated in the dark for 20 min at RT. The 
fluorescent products, monoamide R110 (R110) were determined using a FLIPR I (Molecular Devices, 
Sunnyvale, CA, USA) by measuring emission fluorescence at 525 nm with 480 nm excitation. 
Caspase-3 activity was reflected by the cleavage of Z-DEVD-R110 to the fluorescent product, R110. 
4.6. Western Blotting 
The western blotting experiments were performed as described previously [33]. Briefly, cultures 
were treated with 30 nM of hoiamide A and incubated at 37 °C for specified times in the culture 
medium. Cultures were then transferred to an ice slurry to terminate treatment. After washing with ice 
cold PBS, cells were harvested in ice-cold lysis buffer containing 50 mM Tris, 50 mM NaCl, 2 mM 
EDTA, 2 mM EGTA, 1% NP-40, 2.5 mM sodium pyrophosphate, 1 mM sodium orthovanadate,  
1 μg/mL leupeptin, 1 μg/mL aprotinin, 1 μg/mL pepstatin and 1 mM phenylmethylsulfonyl fluoride 
just prior to use and incubated for 20 min at 4 °C. Cell lysates were centrifuged at 16,000× g for 10 min 
at 4 °C. The supernatant was assayed by the Bradford method to determine protein content. Equal 
amounts (30 μg) of protein were mixed with the Laemmli sample buffer and boiled 5 min. The 
samples were loaded onto a 12% SDS-PAGE gel and transferred to a nitrocellulose membrane by 
electroblotting. The membranes were blocked in TBST buffer (20 mM Tris, 150 mM NaCl, 0.1% 
Tween 20) with 5% skimmed milk for 1 h at room temperature. After blocking, membranes were 
incubated overnight at 4 °C in primary antibody diluted in TBST buffer containing 5% skimmed milk. 
The blots were washed and incubated with the secondary antibody conjugated with horseradish peroxidase 
for 1 h, washed four times in TBST buffer and exposed with ECL Plus for 3 min. Blots were exposed 
to HyBlot CL film (Denville Scientific, Inc., Metuchen, NJ, USA) and developed. Membranes were 
stripped with stripping buffer (63 mM Tris base, 70 mM SDS, 0.0007% 2-mercaptoethanol, pH = 6.8) 
and reblotted for further use.  
4.7. Fluorescein Diacetate (FDA) and Propidium Iodide (PI) Staining 
The FDA/PI staining was performed as described by Jones and Senft [42] to quantify neuronal 
death. Briefly, neocortical neurons (8–10 DIV) cultured in 12-well plate were treated with vehicle or 
hoiamide A for 24 h. After washing 3X using PBS buffer, 1 mL of PBS buffer containing FDA  
(5 μg/mL) and PI (1 μg/mL) was add to each well and incubated at RT for 5 min. The dye buffer was 
then aspirated and washed 3X using PBS. Images were taken using an Olympus IX71 fluorescent 
microscope by using FITC filter (FDA) and Texas Red filter (PI) and the cells were counted 
automatically using Imaris software (Version 6.4, Bitplane Inc., Saint Paul, MN, USA). 
4.8. Diolistic Labeling 
A Helios Gene Gun System (Bio-Rad, Hercules, CA, USA) was used to deliver DiI coated tungsten 
particles (1.3 µM) (Bio-Rad, Hercules, CA, USA) into paraformaldehyde fixed neocortical neurons as 
Mar. Drugs 2015, 13 916 
 
described previously [27]. Briefly, 2.5–3.5 mg of DiI (Invitrogen, Carlsbad, CA, USA) was dissolved 
in 200 µL of dichloromethane and added over 35 mg tungsten particles. The dye-coated particles were 
chopped to fine particles and re-suspended in 3 mL deionized water and sonicated for 10 min. After 
adding 100 µL of polyvinylpyrrolidone (PVP) stock solution (0.96% PVP in ethanol), the suspension 
was drawn into a PVP pre-coated tefzel tubing and settled for 20–30 min. The tubing was then allowed 
to dry for 5 min before cutting into bullets using a tube cutter. The neocortical neurons grown on cover 
slips were shot post-fixation (1.5% paraformaldehyde) using DiI bullets loaded into a Helios Gene Gun 
and incubated at RT overnight. The cover slips were then mounted on slides and the images were taken 
on an Olympus IX 71 inverted microscope with a CCD camera controlled by Slidebook software 
(Intelligent Imaging Innovations, Inc., Denver, CO, USA). To reduce the effect of paracrine neurotrophic 
factors on neurite growth, only those neurons that were separated from surrounding cells by 
approximately 150 µm were digitally acquired and analyzed. All neurites in a single neuron including 
those from secondary branches were manually traced, and the length was measured by Imaris software 
(Version 6.4, Bitplane Inc., Saint Paul, MN, USA). Total neurite length was calculated by summing all 
the neurite lengths traced and measured on individual neurons.  
4.9. Data Analysis 
Concentration-response curves were analyzed by non-linear regression analysis with the GraphPad 
Prism software (Version 4.0, San Diego, CA, USA). Statistical significance was determined by an 
ANOVA and, where appropriate, a Dunnett’s Multiple Comparison Test (GraphPad Prsim software, 
San Diego, CA, USA). 
5. Conclusions 
In the present study, we demonstrated that nanomolar concentrations of  hoiamide A triggered a 
unique neuronal death profile involving both necrotic and apoptotic mechanisms that may derive from 
an interaction with a common molecular target. Pharmacological evaluation demonstrated that hoiamide 
A-induced neuronal death required both JNK and caspase signaling pathways. The potent 
neurotoxicity and unique neuronal death profile of hoiamide A represents a novel neurotoxic 
chemotype from marine cyanobacteria.  
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